PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer.
Xu JM, Wang Y, Wang YL, Wang Y, Liu T, Ni M, Li MS, Lin L, Ge FJ, Gong C, Gu JY, Jia R, Wang HF, Chen YL, Liu RR, Zhao CH, Tan ZL, Jin Y, Zhu YP, Ogino S, Qian ZR.
Xu JM, et al. Among authors: wang hf, wang y, wang yl.
Clin Cancer Res. 2017 Aug 15;23(16):4602-4616. doi: 10.1158/1078-0432.CCR-16-2738. Epub 2017 Apr 19.
Clin Cancer Res. 2017.
PMID: 28424201
Free PMC article.